Yung H. Chyung
Plus aucun poste en cours
Fortune : 1 M $ au 31/03/2024
Profil
Yung H.
Chyung is currently the Chief Medical Officer at Tourmaline Bio, Inc. Prior to this, he was the Chief Medical Officer at Scholar Rock, Inc. and Scholar Rock Holding Corp.
from 2016 to 2022.
He was also the Vice President-Medical Research at Dyax Corp.
from 2011 to 2016.
Dr. Chyung received his doctorate degree from Harvard Medical School in 2003 and his undergraduate degree from Harvard College in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,22% | 23/10/2023 | 56 836 ( 0,22% ) | 1 M $ | 31/03/2024 |
Postes actifs de Yung H. Chyung
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Yung H. Chyung
| Sociétés | Poste | Fin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 30/06/2022 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 30/06/2022 |
| DYAX CORP. | Corporate Officer/Principal | 01/02/2016 |
Formation de Yung H. Chyung
| Harvard Medical School | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
